Literature DB >> 679434

Systemic and regional hemodynamics in low, normal and high cardiac output borderline hypertension.

F H Messerli, J G De Carvalho, B Christie, E D Frohlich.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 679434     DOI: 10.1161/01.cir.58.3.441

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  10 in total

Review 1.  Treatment of resistant hypertension.

Authors:  Sandra J Taler
Journal:  Curr Hypertens Rep       Date:  2005-10       Impact factor: 5.369

Review 2.  When is discontinuation of antihypertensive therapy indicated?

Authors:  R E Schmieder; J K Rockstroh
Journal:  Cardiovasc Drugs Ther       Date:  1990-12       Impact factor: 3.727

3.  Hemodynamic effects of antihypertensive agents.

Authors:  P Lund-Johansen
Journal:  Can Med Assoc J       Date:  1983-01-01       Impact factor: 8.262

4.  Circulatory model of vascular and interstitial distribution kinetics of rocuronium: a population analysis in patients.

Authors:  Michael Weiss; Marije Reekers; Jaap Vuyk; Fred Boer
Journal:  J Pharmacokinet Pharmacodyn       Date:  2010-12-03       Impact factor: 2.745

5.  Hemodynamic and hormonal effects of propranolol on patients with essential hypertension during head-up tilting: a comparison between normal and low cardiac index groups.

Authors:  O Kida; Y Morotomi; T Higa; K Tanaka
Journal:  Heart Vessels       Date:  1985-08       Impact factor: 2.037

6.  Essential hypertensive vascular disease: pathogenesis and pathophysiology.

Authors:  G R Dreslinski; E D Frohlich; F H Messerli; F G Dunn
Journal:  Bull N Y Acad Med       Date:  1981-06

7.  Recent pathogenic aspects in essential hypertension and hypertension associated with diabetes mellitus.

Authors:  P Weidmann
Journal:  Klin Wochenschr       Date:  1980-10-01

8.  Diltiazem maintains renal vasodilation without hyperfiltration in hypertension: studies in essential hypertension man and the spontaneously hypertensive rat.

Authors:  T Isshiki; C Amodeo; F H Messerli; B L Pegram; E D Frohlich
Journal:  Cardiovasc Drugs Ther       Date:  1987-12       Impact factor: 3.727

Review 9.  Cardiovascular pathophysiology of essential hypertension: a clue to therapy.

Authors:  F H Messerli; H O Ventura
Journal:  Drugs       Date:  1985       Impact factor: 9.546

Review 10.  Abnormalities of autonomic nervous control in human hypertension.

Authors:  S Julius
Journal:  Cardiovasc Drugs Ther       Date:  1994-03       Impact factor: 3.727

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.